Journal of Dermatology Research and Skin Care

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Opinion Article - Journal of Dermatology Research and Skin Care (2023) Volume 7, Issue 2

Managing immune-mediated skin diseases: Understanding and coping with common conditions.

Patsatsi Kyriakou*

Department of Dermatology, Faculty of Medicine, Virgen Macarena Hospital, Avda Dr Fedriani s/n., 41009, Seville, Spain

*Corresponding Author:
Patsatsi Kyriakou
Department of Dermatology, Faculty of Medicine
Virgen Macarena Hospital
Avda Dr Fedriani s/n., 41009, Seville, Spain
E-mail: patsatsi.k854@auth.gr

Received: 01-Mar-2023, Manuscript No. AADRSC-23-90017; Editor assigned: 03-Mar-2023, PreQC No. AADRSC-23-90017(PQ); Reviewed: 17-Mar-2023, QC No AADRSC-23-90017; Revised: 22-Mar-2023, Manuscript No. AADRSC-23-90017(R); Published: 29-Mar-2023, DOI:10.35841/aadrsc-7.2.139

Citation: Kyriakou P. Managing Immune-Mediated Skin Diseases: Understanding and Coping with Common Conditions. Dermatol Res Skin Care. 2023;7(2):139

Visit for more related articles at Journal of Dermatology Research and Skin Care

Abstract

Immune-mediated skin diseases are a group of skin disorders that are caused by an abnormal immune response. This type of disease occurs when the body's immune system attacks the body's own tissues, leading to inflammation and damage. Common immune-mediated skin diseases include atopic dermatitis, psoriasis, alopecia areata, bullous pemphigoid, and lupus erythematosus. These conditions can range from mild to severe and can have a significant impact on a person's quality of life. Treatment options for immune-mediated skin diseases include topical medications, antihistamines, corticosteroids, immunosuppressive drugs, and phototherapy. It is important for individuals to seek medical advice if they are experiencing symptoms of an immune-mediated skin disease.

Keywords

Dermatitis, Psoriasis, Alopecia areata, Bullous pemphigoid, Lupus erythematosus.

Introduction

Immune-mediated skin diseases are a group of skin disorders that occur when the body's immune system mistakenly attacks its own tissues. This leads to inflammation and damage to the skin and other parts of the body. The exact cause of immunemediated skin diseases is not always clear, but a combination of genetic and environmental factors is often involved. Some of the most common types of immune-mediated skin diseases include atopic dermatitis, psoriasis, alopecia areata, bullous pemphigoid, and lupus erythematosus. These conditions can range from mild to severe and can significantly impact a person's quality of life. Early diagnosis and proper treatment are crucial in managing these diseases and improving outcomes. In this article, we will discuss the various types of immune-mediated skin diseases, their causes, and available treatments. Immune-mediated skin diseases are a group of skin disorders that occur as a result of an abnormal immune response [1].

The immune system, which is responsible for protecting the body from harmful pathogens, begins to attack the body's own tissues, leading to inflammation and damage. These conditions can range from mild to severe and can have a significant impact on a person's quality of life. One of the most common immune-mediated skin diseases is atopic dermatitis, also known as eczema. This condition affects millions of people worldwide and is characterized by red, itchy, and dry skin. The exact cause of atopic dermatitis is not known, but it is thought to be the result of a combination of genetic and environmental factors. In people with atopic dermatitis, the skin barrier is weakened, allowing allergens and irritants to penetrate and trigger an immune response [2].

Another common immune-mediated skin disease is psoriasis. This condition causes patches of red, scaly skin to develop, typically on the elbows, knees, scalp, and lower back. The skin cells in these areas grow too quickly, leading to the formation of thick, flaky scales. The cause of psoriasis is not entirely understood, but it is believed to be the result of an overactive immune system. People with psoriasis are more likely to develop other autoimmune disorders, such as rheumatoid arthritis or Crohn's disease.

Alopecia areata

Alopecia areata is an autoimmune disease that affects the hair follicles. This condition causes patches of hair to fall out, leaving smooth, bald areas on the scalp or other parts of the body. The cause of alopecia areata is not known, but it is believed to be the result of an overactive immune system that attacks the hair follicles. This disease can have a significant impact on a person's self-esteem and quality of life, and there is currently no cure [3].

Bullous pemphigoid

Bullous pemphigoid is a rare autoimmune skin disease that causes the formation of large, fluid-filled blisters on the skin. These blisters can be extremely painful and can lead to infection. The exact cause of bullous pemphigoid is not known, but it is believed to be the result of an overactive immune system that attacks the proteins in the skin. This disease is most commonly found in people over the age of 60, and there is currently no cure.

Lupus erythematosus

Lupus erythematosus is a chronic autoimmune disease that can affect the skin, joints, kidneys, heart, and other organs. This disease is characterized by the formation of a butterfly-shaped rash on the face, as well as other symptoms such as fatigue, joint pain, and fever. The cause of lupus erythematosus is not entirely understood, but it is believed to be the result of a combination of genetic and environmental factors. People with lupus are more likely to develop other autoimmune disorders, such as rheumatoid arthritis or Crohn's disease [4].

The treatment of immune-mediated skin diseases varies depending on the specific condition and the severity of symptoms. In many cases, topical medications and ointments can help to relieve itching and reduce inflammation. Antihistamines may also be used to help control itching. In more severe cases, corticosteroids may be prescribed to reduce inflammation, and immunosuppressive drugs may be used to slow down the immune response. In some cases, phototherapy or ultraviolet light therapy may be used to help control symptoms [5].

Conclusion

Immune-mediated skin diseases are a group of conditions that can have a significant impact on a person's quality of life. These diseases are caused by an abnormal immune response, leading to inflammation and damage in the skin and other tissues. Despite the availability of various treatments, there is currently no cure for these conditions. It is important for individuals to seek medical advice if they are experiencing symptoms of an immune-mediated skin disease, as early diagnosis and treatment can improve outcomes and help to manage symptoms. Further research is needed to better understand the causes of these diseases and to develop more effective treatments for those affected by immune-mediated skin diseases.

References

  1. Cherin P, Herson S, Wechsler B, et al. Effectiveness of intravenous immunoglobulins in polymyositis and dermatomyositis. An open trial in 15 patients. Presse Med (1893). 1991;20(6):244-9.
  2. Indexed at, Google Scholar

  3. Cherin P, Pelletier S, Teixeira A, et al. Results and long‐term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty‐five adult patients. Arthritis Rheumat. 2002;46(2):467-74.
  4. Indexed at, Google Scholar, Cross Ref

  5. Rossi F, Kazatchkine MD. Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig. J Immun J Immun Balt. 1989;143(12):4104-9.
  6. Indexed at, Google Scholar

  7. Sultan YM, Maisonneuve P, Kazatchkine MD, et al. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet. 1984;324(8406):765-8.
  8. Indexed at, Google Scholar, Cross Ref

  9. Andersson U, Björk L, Skansén‐Saphir U, et al. Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev. 1994;139(1):21-42.
  10. Indexed at, Google Scholar, Cross Ref

Get the App